Artificial Intelligence Enabled Imaging Biomarkers for Distinguishing Pseudoprogression from True Progression after Cellular Immunotherapy in Glioblastoma
Year: 2026
Type: preprint
Abstract: Pseudoprogression, transient radiographic worsening caused by treatment-related inflammation rather than tumor growth, is a well-recognized pitfall after chemoradiotherapy for glioblastoma and is becoming more relevant as checkpoint inhibitors and cellular immunotherapies such as chimeric antigen receptor (CAR) T cells enter clinical testing. Conventional structural magnetic resonance imaging (MRI) cannot reliably separate pseudoprogression from true progression, exposing patients to premature treatment discontinuation or unnecessary intensification. Quantitative, artificial-intelligence-based imaging analysis (radiomics, and its molecular extension radiogenomics) is an emerging candidate solution. In this narrative review we synthesize the evidence on radiomics and radiogenomics for differentiating pseudoprogression from true progression in glioblastoma, with emphasis on the immunotherapy and cellular-therapy context. We summarize the pathobiology and reported frequency of pseudoprogression after standard and immune-based therapies, outline the limitations of current response criteria (RANO, iRANO, RANO 2.0), and review representative studies of texture analysis, hand-crafted radiomics, deep-learning radiomics, and radiogenomics. Although several studies report promising discrimination (reported area-under-the-curve values of approximately 0.88-0.92 in different cohorts), the evidence is limited by small sample sizes, retrospective designs, inconsistent definitions and protocols, and infrequent external validation. Progress will require prospective multicenter cohorts with standardized acquisition and segmentation, adherence to TRIPOD and CLAIM reporting standards, transparent and interpretable models, and integration with clinical, molecular, and liquid-biopsy data. A dedicated evidence base specific to cellular immunotherapy is urgently needed.
Source: Research Square
Authors: chunlei he(Conceptualization, Funding acquisition, Project administration, Resources, Visualization, Writing – original draft, Writing – review & editing), yafeng wang(Formal analysis, Investigation, Methodology, Software, Validation), wubing zhou(Methodology, Software), xiaotong zhao(Data curation, Investigation)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235060347
